“Animal Citizenship” by Donaldson and Kymlicka

 

 

1) Based on “The Apology” by Plato – (i) provide an elucidation of Socrates’ indictments; (ii) elaborate his defences against these charges; (iii) provide three arguments to convince your reader that the asking of questions can count as a form of corruption (specifically, an act that can corrupt others); and (iv) provide three arguments to convince your reader that the asking of questions may not count as a form of corruption (specifically, an act that can corrupt others).
2) Based on lectures and “The Apology” by Plato – Socrates never advances positive knowledge, but seeks knowledge by attempting to discover what cannot be a case of knowledge based on the reasons others offer as evidence for that “knowledge”. How does this largely negative exercise help us discover/move towards knowledge?
3) Ethical Egoism – (i) provide an elucidation of the various versions of ethical egoism that exist (look to the textbook AND my lecture(s)); (ii) provide two arguments not included in the TEXTBOOK for why ethical egoism (specify which version(s) you are referencing) contains internal tensions/confusions/problems that make the position implausible; and (iii) provide two arguments for why even if ethical egoism is true/plausible (specify which version(s) you are referencing), ethical egoism does not challenge our ability to engage in practical ethics together.
3) Utilitarianism – (i) elaborate what utilitarianism amounts to as described in the textbook; (ii) provide four arguments not referenced in the textbook to suggest that utilitarianism suffers from tensions/confusions/problems; and (iii) defend utilitarianism on two grounds not offered by the textbook itself.
4) Kant’s Deontology – (i) elaborate Kant’s account of deontology (his Categorical Imperative); (ii) outline four issues not referenced in the textbook to argue that Kant’s deontology suffers from tensions/confusions/problems; and (iii) defend Kant’s deontology on two grounds not offered by Kant himself.
5) Virtue Ethics – (i) elaborate Aristotle’s account of virtue ethics; (ii) outline four issues not referenced in the textbook to argue that virtue ethics suffers from tensions/confusions/problems; and (iii) defend virtue ethics on two grounds not offered by Aristotle himself or the textbook.
Choose two of the following:
6) “All Animals are Equal” by Singer – (i) elaborate Singer’s argument in this piece; (ii) outline three issues not referenced in the textbook to argue that Singer’s argument suffers from tensions/confusions/problems; and (iii) defend Singer’s argument on three grounds not offered by Singer himself or by the textbook.
7) “Animal Citizenship” by Donaldson and Kymlicka – (i) elaborate the authors’ argument in this piece; (ii) outline three issues not referenced in the textbook to argue that the authors’ argument suffers from tensions/confusions/problems; and (iii) defend the authors’ argument on three grounds not offered by the authors themselves or by the textbook.

 

Sample Solution

eveloped medications reach screening while a low 5% of medications are approved (FDA). With these risks, pharmaceutical companies have fixated on the promotion of their current drugs as opposed to the release of new medications.
However, pharmaceutical companies have long justified their pricing by defensively arguing that revenue goes towards the research and development of new medication. In a six year review (2011-2017) of thirteen of the large pharmaceutical companies, 17% of total revenue was spent on research and development with a staggering 60% spent on the marketing of their current products (True). Over the years, pharmaceutical companies have been able to allocate their profits towards their gains. After all, the pharmaceutical industry is a lucrative business that have thrived under the laxity of regulations and have figured out ways to further increase profit margins. As these problems have become more apparent, bills such as California’s drug transparency bill of 2017 have been enacted. This bill mandates these companies to provide 60 day warnings of greater than or equal to 16% price increases (Upenn). Although the idea behind this bill is a step towards better regulations, it has yet to be adapted on a national level.

As mentioned previously, the Food and Drug Administration is the sector that awards market exclusivity while the US Patent and Trademark Office is responsible for patent exclusivity. Despite having a specific timeframe for patents, pharmaceutical companies actively seek extensions through many ways. Some of their methodology includes simply applying for and extension and submitting patent applications for non-therapeutic aspects of drugs such as coating and formulation (JAMA). The del

This question has been answered.

Get Answer
WeCreativez WhatsApp Support
Our customer support team is here to answer your questions. Ask us anything!
👋 Hi, Welcome to Compliant Papers.